NuCana
Price & Volume
Stats
See more52W Range | $2.78-$330 |
Market Cap | $7.5M |
Shares Short | 324,056 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $394.72 |
News
See moreYahoo Finance • 15 days ago
NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update
Yahoo Finance • 24 days ago
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China
Yahoo Finance • last month
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
Yahoo Finance • 3 months ago
NuCana receives compliance notification from Nasdaq
About
CEO | Mr. Hugh Stephen Griffith |
Address | 3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 20 |
